Target intelligence / Profile preview

Cell delivery

Molecular classification
Other (not a molecule, receptor, or protein family)
01

Overview

Cell delivery" refers to a broad class of biomedical techniques and strategies designed to transport therapeutic agents (such as drugs, genetic material, or functional cells) into specific target tissues, organs, or individual cells. Delivery methods include carrier-mediated approaches (using immune cells, stem cells, or other cells as vehicles), encapsulation in biomaterials or engineered scaffolds, and the use of nanotechnology-based carriers. Cell delivery is fundamental to numerous advanced therapies, including gene therapy, CAR-T cell therapy, regenerative medicine, and targeted treatments of cancer, infection, and inflammatory diseases. Because it is a process and not a single protein or molecule, it lacks standard molecular classifications, interacting drugs, or canonical abbreviations. Note: This entry should be flagged as not a valid molecular target for purposes that require protein, receptor, or enzyme specificity.

Other names
Cell-based deliveryCell-mediated deliveryCell therapy deliveryIntracellular delivery (in some contexts as a related term)
02

Mechanism of action

Targeted delivery via carrier cells (e.g., immune cells, stem cells) Trojan Horse migration to sites of injury or disease (e.g., brain, tumor) Encapsulation and controlled release (e.g., ECM scaffolds, hydrogels) Direct injection or transplantation of therapeutic cells

03

Biological functions

Drug deliveryGene deliveryCellular therapy deliveryTissue engineering supportTargeted transport of therapeutics
04

Disease associations

CancerInflammationInfectionNeurodegenerative diseaseType 1 diabetes (in context of islet transplantation)Other
05

Safety considerations

Limited drug loading capacity in carrier cellsPremature release of therapeutic agentsMigration and engraftment efficiency of carrier cells or delivered payloadImmunogenicity and toxicity of delivery materialsRisks of uncontrolled cell proliferation (in cellular therapies)Inflammatory responses to biomaterials or engineered tissues

Beyond the preview

Go deeper on Cell delivery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell delivery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call